Table 2.
Total sample |
Nondiabetic patients |
Diabetic patients |
|
---|---|---|---|
n = 587 | n = 523 | n = 64 | |
Trial intervention | |||
Injection | 294 (50) | 263 (50) | 31 (48) |
Standard care | 293 (50) | 260 (50) | 33 (52) |
Primary total joint replacement | |||
Hip | 300 (51) | 276 (53) | 24 (37) |
Knee | 287 (49) | 247 (47) | 40 (63) |
Age, mean (SD) | 68 (10) | 68 (10) | 70 (8) |
Sex | |||
Female | 325 (55) | 295 (56) | 30 (47) |
Male | 262 (45) | 228 (44) | 34 (53) |
BMI, mean (SD) | 31 (6) | 31 (6) | 34 (6) |
≤ 30 | 303 (52) | 282 (54) | 21 (33) |
> 30 | 284 (48) | 241 (46) | 43 (67) |
EQ VASa, n | 553 | 492 | 61 |
mean (SD) | 66 (20) | 66 (20) | 64 (19) |
EQ-5D Scoreb, n | 555 | 495 | 60 |
mean (SD) | 0.42 (0.32) | 0.43 (0.32) | 0.37 (0.31) |
FCIc (Number of comorbidities) | |||
192 (33) | 178 (34) | 14 (22) | |
2 | 168 (29) | 156 (30) | 12 (19) |
3 | 115 (20) | 102 (19) | 13 (20) |
112 (19) | 87 (17) | 25 (39) | |
HADSd Total, n | 567 | 505 | 62 |
mean (SD) | 13 (7) | 13 (7) | 13 (6) |
WOMACe Pain, n | 587 | 523 | 64 |
mean (SD) | 42 (17) | 43 (18) | 41 (15) |
WOMAC Function, n | 558 | 499 | 59 |
mean (SD) | 44 (18) | 44 (18) | 43 (16) |
WOMAC Stiffness, n | 548 | 487 | 61 |
mean (SD) | 44 (22) | 43 (22) | 44 (18) |
WOMAC Total, n | 537 | 479 | 58 |
mean (SD) | 44 (17) | 44 (17) | 44 (14) |
EQ visual analogue scale (0–100, worst to best health state).
EQ-5D 3L descriptive system.
Modified Functional Co-morbidity Index without BMI and diabetes diagnoses (categorized sum of the 16 remaining diagnoses).
Hospital Anxiety and Depression Scale with anxiety and depression scores combined (0–42, best to worst distress state).
Western Ontario and McMaster Universities Osteoarthritis Index (0–100 worst to best pain, function, stiffness or total score).